Novartis

M&A

Novartis agrees to buy Medicines Co. in US$6.8 bil deal

(Nov 25): Novartis AG agreed to buy Medicines Co. for an equity value of about US$6.8 billion ($9.3 billion), snapping up a promising cholesterol drug and adding to a string of acquisitions for Chief Executive Officer Vas Narasimhan.

Healthcare

Singapore's billion-dollar headache

SINGAPORE (Sept 18): How much does a migraine cost? The type of throbbing headaches cost Singapore some $1.04 billion last year, according to new research released Wednesday by the DUKE-NUS Medical School and Novartis.

Broker's Calls

Switch out of Frasers Centrepoint Limited to this undervalued stock, recommends Lim & Tan

SINGAPORE (Sept 12): Lim & Tan Securities is recommending that investors switch from Frasers Centrepoint Limited (FCL) to UOL Group, given the latter’s cheaper price-to-book valuation (PB/V) of 0.78 times.
×